F-group (family)
5001.1.1.1 7tm_1
Ligands and drugs
4,591
Member domains
1,363
with ligand contacts (≤ 4 Å)
29.7% of members
962
with DrugDomain annotations
21.0% of members
665
with a DrugBank compound
14.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5001.1.1.1 belongs to X-group 5001 Family A G protein-coupled receptor-like, which binds 10.2 ligand superclasses per 20 proteins, broader than 95% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04540 | CLR | Cholesterol | 231 |
| DB03796 | PLM | Palmitic Acid | 79 |
| DB08558 | SOG | 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL | 36 |
| DB01238 | — | Aripiprazole | 31 |
| DB08770 | ZMA | 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol | 30 |
| DB00408 | — | — | 24 |
| DB00246 | — | — | 21 |
| DB00363 | — | — | 20 |
| DB14185 | — | — | 20 |
| DB00248 | — | — | 19 |
| DB01200 | — | Bromocriptine | 19 |
| DB06216 | — | — | 19 |
| DB00141 | NAG | N-Acetylglucosamine | 18 |
| DB01224 | — | — | 18 |
| DB00696 | — | Ergotamine | 16 |
| DB01403 | — | — | 16 |
| DB00321 | — | Amitriptyline | 15 |
| DB00589 | — | Lisuride | 15 |
| DB04079 | HTO | Heptane-1,2,3-Triol | 15 |
| DB08347 | P32 | 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile | 15 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CLR | CHOLESTEROL | 372 |
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 172 |
| OLA | OLEIC ACID | 160 |
| NAmetal | SODIUM ION | 122 |
| PLM | PALMITIC ACID | 88 |
| RET | RETINAL | 40 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 39 |
| SOG | octyl 1-thio-beta-D-glucopyranoside | 35 |
| 2CV | HEGA-10 | 32 |
| OLB | (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 30 |
| ZMA | 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol | 30 |
| ZNmetal | ZINC ION | 30 |
| CAmetal | CALCIUM ION | 23 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 23 |
| PGW | (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl(9Z)-octadec-9-enoate | 22 |
| HGmetal | MERCURY (II) ION | 17 |
| J40 | [(2R)-1-[oxidanyl-[(2R,3R,5S,6R)-2,3,5,6-tetrakis(oxidanyl)-4-phosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-3-tetradecanoyloxy-propan-2-yl] (5E,8E)-hexadeca-5,8,11,14-tetraenoate | 17 |
| 7LD | (8alpha)-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide | 15 |
| HSM | HISTAMINE | 15 |
| HTO | HEPTANE-1,2,3-TRIOL | 15 |